Also trades as: ASBP (NASDAQ) · $vol 6M
ASBPW NASDAQ
Aspire Biopharma Holdings, Inc.
1W: -9.1%
1M: -1.6%
3M: +25.9%
YTD: -3.2%
1Y: -52.0%
$0.02
+0.00 (+35.34%)
Weekly Expected Move ±57.1%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$6K
+0.0% ▲
Gross Profit
-$116
+0.0% ▲
Operating Income
-$19M
-526.5% ▼
Net Income
-$24M
-95.3% ▼
EPS (Diluted)
$-16.38
-4210.5% ▼
EBITDA
-$19M
-66.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $6K |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $6K |
| Gross Profit | $0 | $0 | $0 | -$116 |
| Gross Margin | — | — | — | -1.9% |
| R&D Expenses | $175K | $72K | $0 | $924K |
| SG&A Expenses | $421K | $1M | $3M | $18M |
| Operating Expenses | $976K | $1M | $3M | $19M |
| Operating Income | -$976K | -$1M | -$3M | -$19M |
| Operating Margin | — | — | — | -312016.9% |
| Interest Expense | $0 | $9K | $892K | -$9M |
| Income Before Tax | -$596K | $4M | -$13M | -$24M |
| Tax Expense | $626 | $0 | $0 | $0 |
| Net Income | -$597K | $4M | -$13M | -$24M |
| Net Margin | — | — | — | -394725.1% |
| EPS (Diluted) | $-0.07 | $0.54 | $-1.52 | $-16.38 |
| EBITDA | -$596K | $4M | -$12M | -$19M |
| Shares Outstanding | 8M | 8M | 8M | 1M |